Yvan Beaussant

820 total citations
35 papers, 392 citations indexed

About

Yvan Beaussant is a scholar working on Clinical Psychology, Organic Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yvan Beaussant has authored 35 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Clinical Psychology, 15 papers in Organic Chemistry and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yvan Beaussant's work include Psychedelics and Drug Studies (19 papers), Chemical synthesis and alkaloids (15 papers) and Palliative Care and End-of-Life Issues (13 papers). Yvan Beaussant is often cited by papers focused on Psychedelics and Drug Studies (19 papers), Chemical synthesis and alkaloids (15 papers) and Palliative Care and End-of-Life Issues (13 papers). Yvan Beaussant collaborates with scholars based in United States, France and Sweden. Yvan Beaussant's co-authors include Régis Aubry, Lucas Morin, Philippe Rochigneux, Christophe Tournigand, François Goldwasser, Jean‐Luc Raoul, Rick Doblin, Ana Cláudia Mesquita Garcia, Lucas Oliveira Maia and Brian S. Barnett and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Yvan Beaussant

29 papers receiving 386 citations

Peers

Yvan Beaussant
Ali John Zarrabi United States
Clive Cooke Australia
Liz Roffe United Kingdom
Nora Abdul Aziz United States
V. Watkins United States
Ali John Zarrabi United States
Yvan Beaussant
Citations per year, relative to Yvan Beaussant Yvan Beaussant (= 1×) peers Ali John Zarrabi

Countries citing papers authored by Yvan Beaussant

Since Specialization
Citations

This map shows the geographic impact of Yvan Beaussant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvan Beaussant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvan Beaussant more than expected).

Fields of papers citing papers by Yvan Beaussant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvan Beaussant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvan Beaussant. The network helps show where Yvan Beaussant may publish in the future.

Co-authorship network of co-authors of Yvan Beaussant

This figure shows the co-authorship network connecting the top 25 collaborators of Yvan Beaussant. A scholar is included among the top collaborators of Yvan Beaussant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvan Beaussant. Yvan Beaussant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beaussant, Yvan, Zachary Sager, Caitlin W. Brennan, et al.. (2025). Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy. BMJ Supportive & Palliative Care. 16(2). 423–433.
2.
Tarbi, Elise C., Cara Wallace, Yvan Beaussant, et al.. (2024). Top Ten Tips Palliative Care Clinicians Should Know About Attending to the Existential Experience. Journal of Palliative Medicine. 27(10). 1379–1389. 6 indexed citations
3.
Sager, Zachary, Antoine Yrondi, B. Anderson, et al.. (2024). Older adults in psychedelic-assisted therapy trials: A systematic review. Journal of Psychopharmacology. 38(1). 33–48. 8 indexed citations
4.
Fischer, Stacy M., Ali John Zarrabi, & Yvan Beaussant. (2024). Bringing Psychedelic-Assisted Therapy from Psychiatry to Palliative Care. Journal of Pain and Symptom Management. 67(5). e574–e575.
5.
Sager, Zachary, Antoine Yrondi, B. Anderson, et al.. (2024). Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review. European Psychiatry. 67(S1). S232–S232.
6.
Schmid, Yasmin, et al.. (2024). Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases. Cochrane Database of Systematic Reviews. 2024(9). CD015383–CD015383. 8 indexed citations
7.
Richards, William A., Yvan Beaussant, Rezvan Ameli, et al.. (2023). Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder. Cancer. 130(7). 1137–1146. 33 indexed citations
9.
Lester, Ethan G., Ottavio V. Vitolo, Alice W. Flaherty, et al.. (2023). “When Will All of This End?”. The Journal of Clinical Psychiatry. 85(1).
10.
11.
Miller, Megan E., et al.. (2023). Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy. PubMed. 1(3). 124–129. 2 indexed citations
12.
Curseen, Kimberly, et al.. (2023). Psychedelics and Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care. Clinics in Geriatric Medicine. 39(3). 423–436. 2 indexed citations
13.
Maia, Lucas Oliveira, Yvan Beaussant, & Ana Cláudia Mesquita Garcia. (2022). The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review. Journal of Pain and Symptom Management. 63(6). e725–e738. 30 indexed citations
14.
Sanders, Justin J., et al.. (2022). Psychedelic-Assisted Therapies in Patients With Serious Illness: Opportunities and Challenges. Psychiatric Annals. 52(9). 359–364. 2 indexed citations
15.
Piechotta, Vanessa, et al.. (2022). Psychedelic/entactogen-assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care. Cochrane Database of Systematic Reviews. 2022(11). 4 indexed citations
16.
Beaussant, Yvan, William E. Richards, Ira Byock, et al.. (2020). An Agenda of Psychedelic-Assisted Therapy Research in Seriously Ill Patients: Highlights from the Harvard Radcliffe Institute Exploratory Seminar (FR405). Journal of Pain and Symptom Management. 59(2). 446–447. 1 indexed citations
17.
Barnett, Brian S., Yvan Beaussant, Franklin King, & Rick Doblin. (2020). Psychedelic knowledge and opinions in psychiatric professional conference attendees: Survey instrument. Figshare. 2 indexed citations
18.
Beaussant, Yvan, Étienne Daguindau, Adrien Chauchet, et al.. (2018). Hospital end-of-life care in haematological malignancies. BMJ Supportive & Palliative Care. 8(3). 314–324. 41 indexed citations
19.
Pazart, Lionel, Marie‐Christine Rousseau, Pierre Decavel, et al.. (2017). Exploring the perceptions of physicians, caregivers and families towards artificial nutrition and hydration for people in permanent vegetative state: How can a photo-elicitation method help?. PLoS ONE. 12(10). e0186776–e0186776. 3 indexed citations
20.
Rochigneux, Philippe, Jean‐Luc Raoul, Yvan Beaussant, et al.. (2016). Use of chemotherapy near the end of life: what factors matter?. Annals of Oncology. 28(4). 809–817. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026